Remove Packaging Remove Pharmacy Remove Trials
article thumbnail

Indian pharma sees immense importance in US FDA guidance on aluminum content and labelling in parenteral nutrition

AuroBlog - Aurous Healthcare Clinical Trials blog

Indian pharma sees immense value in US FDA’s insistence for aluminum content and labelling recommendations for the Small Volume Parenterals Drug Products and Pharmacy Bulk Packages. Pharma companies in the country have increasingly made a shift to nutritional based prescription and over the counter products.

Packaging 188
article thumbnail

FDA committee recommends AstraZeneca and Sanofi’s RSV prophylactic nirsevimab

Pharmaceutical Technology

The drug performed “extraordinarily well” in a variety of cohorts, said Nimish Patel, PharmD, professor of clinical pharmacy at University of California San Diego. The AMDAC reviewed data from three late-stage trials, which included the Phase III MELODY (NCT03979313) and Phase II/III MEDLEY studies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Here are the Latest Sustainability Movements in the Grocery Industry

XTalks

Kroger, America’s largest grocery chain, announced last month it would be expanding an online trial with Loop , a circular economy platform focused on reusable packaging for branded products. Now, the trial has resumed in 25 Fred Meyer store locations in Portland, Oregon. Zero-Waste Grocery Stores.

article thumbnail

Warning of counterfeit ivermectin tablets sold via social media

Sciensano

In 2021, a total of 12 529 counterfeit ivermectin tablets originating from postal packages were seized. These tablets are regularly found in postal packages to this day. In 2021, a total of 12 529 counterfeit ivermectin tablets originating from postal packages were seized. Do you have doubts about a website or a medicine?

article thumbnail

RECOVERY Trial Data Monitoring Committee Recommends Continuing Evaluation of REGN-COV2 in All Hospitalized Patients

The Pharma Data

Regeneron announced today an update from the independent data monitoring committee (DMC) for the United Kingdom-based RECOVERY trial evaluating REGN-COV2 in hospitalized patients with COVID-19. The DMC letter is available here: [link]. Department of Health and Human Services under OT number: HHSO100201700020C.

Trials 52
article thumbnail

Six months after authorization, what do we know about Paxlovid?

pharmaphorum

Paxlovid consists of two different drugs, nirmatrelvir 150mg tablets co-packaged with ritonavir 100mg tablets. In clinical trials, 5.6 Although preliminary trial data from Pfizer found rebound in 1 to 2 percent of patients, it occurred in both placebo and treatment groups. How does the drug work?

Drugs 105
article thumbnail

Merck’s Winrevair Wins FDA Approval as First-in-Class Treatment for Pulmonary Arterial Hypertension (PAH)

XTalks

XTALKS WEBINAR: Improving Patient Recruitment Through Enhanced Data Visibility Live and On-Demand: Monday, May 13, 2024 , at 9am EDT (3pm CEST / EU-Central) Register for this free webinar to gain insights into how supply chain management principles can be quickly applied to patient recruitment processes across clinical trials.